GlassScriptPhysician profile
Chris N Bryant
NPI 1750313748
$3,206.16
in general payments reported to CMS, 2019-2025
21 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $186 · 2021: $39.42 · 2022: $1,566 · 2023: $460 · 2024: $153 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,229.14 | 2022-2023 | |
| Wright Medical Technology, INC. | $289.13 | 2019-2020 | |
| Organogenesis INC. | $217.37 | 2021-2025 | Puraply Wound Matrix, Nushield |
| Osiris Therapeutics INC. | $205.66 | 2019 | |
| Nevro Corp. | $198.88 | 2022-2023 | Senza |
| Mimedx Group, INC. | $194.67 | 2025 | |
| Smith+Nephew, INC. | $149.47 | 2019-2024 | Collagenase Santyl, Regranex |
| Abbvie INC. | $146.16 | 2023 | Dalvance |
| Linvatec Corporation | $132.57 | 2022 | |
| Melinta Therapeutics, LLC | $123.15 | 2019 | |
| Stryker Corporation | $119.18 | 2022 | |
| Acumed LLC | $46.33 | 2023 | Acumed, Osteomed |
| Globus Medical, INC. | $32.49 | 2025 | Senza |
| Medartis INC. | $20.57 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.71 | 2023 | Seglentis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $17.27 | 2024 | Miro3d |
| Bioventus LLC | $15.48 | 2025 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $13.54 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.09 | 2022 | |
| Zyla Life Sciences, INC. | $11.20 | 2019 | |
| Paragon 28, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.